Genmab — December 2017

[E_L]

Genmab Looks Attractive As Company Raises Its Full-Year Outlook https://seekingalpha.com/article/4133008-genmab-looks-attractive-company-raises-full-year-outlook

[Plimsoller]

By How much E.L.?

[jkj]

Fin artikel EL, tak for den, Rart at nogen derover begynder at få øjnene op for at Genmab pt. er et røverkøb.

[jenjon]

https://www.tlv.se/beslut/beslut-lakemedel/overklagade-beslut/pagaende/Beslut-att-avsla-ansokan-om-subvention-for-Darzalex-har-overklagats/ - Janssen accepterer ikke bare at de nationale myndigheder ikke kan se fordelen ved Darzalex i Sverige - positivt

[bongobob]

Patent på CD3xCD20 http://www.freshpatents.com/-dt20171214ptan20170355767.php

[bongobob]

Indsendt i januar, lidt sent når man tænker på at Novartis aftalen er fra 2015.

[bibob]

God morgen.

[JørgenVarnæs]

Mornings! Mon ikke der er sendt IND ansøgning på cd3cd20 nu? Har vi i øvrigt fået target på den? Var der ikke tale om noget autoimmunt også?

[E_L]

Bold move by Janssen to go to court in Sweden?

[rex_pacis]

didn't know you could sue states for not buying your products

[rex_pacis]

I don't know much about Swedish law though... Hope we win!

[rex_pacis]

they don't go to court yet @EL they have only complained about the decision

[E_L]

ok rex, thks, i was a bit surprised already

[Parasitism]

http://client2.mailmailmail.net/display.php?M=29924507&C=4fc26eeae080d17f77834637f9601330&L=4942&N=46994&S=228599&utm_source=MailPlatform&utm_medium=email&utm_campaign=Danske+Akiter+-+11.+udgave+2017

[Parasitism]

Se under flyvere i linket

[E_L]

tweetchat Transcript, on SMM, seems ASCENT trial will start Q1 18 - https://www.symplur.com/healthcare-hashtags/MMSM/transcript/?hashtag=MMSM&fdate=12%2F20%2F2017&shour=13&smin=0&tdate=12%2F20%2F2017&thour=14&tmin=0

[bibob]

Thanks E L. Looks like ASCENT will be the new trial in focus. !!

[polle1]

@bibob : hvad er ASCENT ?

[Bulder]

Det har været længe undervejs. Været "på trapperne" i 1½ år nu. http://bsri.myeloma.org/ascent-trial/

[JKY_VH]

Forholdene omkring infusionen af Darzalex er nu så sikre, at Vejle nu nedsætter infusionstiden fra 3,5 timer til 1,5 timer. Darzalex viser dermed endnu en gang sin unikke konkurrencekraft.